تحديث في 19/10/2018
TRS 2°P is a developed stratification system from the TIMI group to predict recurrent cardiovascular events in post-ACS patients. It incorporates 9 readily available clinical characteristics and can identify a ~5-fold gradient in the risk of recurrent cardiovascular events. The score is developed using data from TIMI 50 trial IMPROVE-IT. The score enables clinicians to have a quantitative assessment of individual patients’ recurrent risk.
